LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Synthesis, molecular docking, and in silico ADME/Tox profiling studies of new 1-aryl-5-(3-azidopropyl)indol-4-ones: Potential inhibitors of SARS CoV-2 main protease.

Domínguez-Villa, Francisco Xavier / Durán-Iturbide, Noemi Angeles / Ávila-Zárraga, José Gustavo

Bioorganic chemistry

2020  Volume 106, Page(s) 104497

Abstract: The virus SARS CoV-2, which causes the respiratory infection COVID-19, continues its spread across the world and to date has caused more than a million deaths. Although COVID-19 vaccine development appears to be progressing rapidly, scientists continue ... ...

Abstract The virus SARS CoV-2, which causes the respiratory infection COVID-19, continues its spread across the world and to date has caused more than a million deaths. Although COVID-19 vaccine development appears to be progressing rapidly, scientists continue the search for different therapeutic options to treat this new illness. In this work, we synthesized five new 1-aryl-5-(3-azidopropyl)indol-4-ones and showed them to be potential inhibitors of the SARS CoV-2 main protease (3CLpro). The compounds were obtained in good overall yields and molecular docking indicated favorable binding with 3CLpro. In silico ADME/Tox profile of the new compounds were calculated using the SwissADME and pkCSM-pharmacokinetics web tools, and indicated adequate values of absorption, distribution and excretion, features related to bioavailability. Moreover, low values of toxicity were indicated for these compounds. And drug-likeness levels of the compounds were also predicted according to the Lipinski and Veber rules.
MeSH term(s) Antiviral Agents/chemical synthesis ; Antiviral Agents/metabolism ; Antiviral Agents/pharmacokinetics ; Azides/chemical synthesis ; Azides/metabolism ; Azides/pharmacokinetics ; Catalytic Domain ; Coronavirus 3C Proteases/antagonists & inhibitors ; Coronavirus 3C Proteases/chemistry ; Coronavirus 3C Proteases/metabolism ; Cysteine Proteinase Inhibitors/chemical synthesis ; Cysteine Proteinase Inhibitors/metabolism ; Cysteine Proteinase Inhibitors/pharmacokinetics ; Indoles/chemical synthesis ; Indoles/metabolism ; Indoles/pharmacokinetics ; Internet ; Molecular Docking Simulation ; Protein Binding ; SARS-CoV-2/chemistry
Chemical Substances Antiviral Agents ; Azides ; Cysteine Proteinase Inhibitors ; Indoles ; 3C-like proteinase, SARS-CoV-2 (EC 3.4.22.-) ; Coronavirus 3C Proteases (EC 3.4.22.28)
Language English
Publishing date 2020-11-24
Publishing country United States
Document type Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID 120080-x
ISSN 1090-2120 ; 0045-2068
ISSN (online) 1090-2120
ISSN 0045-2068
DOI 10.1016/j.bioorg.2020.104497
Shelf mark
Zs.A 4207: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top